illions of coronary angiograms are performed annually to obtain information that, when combined with clinical data, guides treatment decisions for patients with coronary artery disease.
part, to determine the presence and severity of coronary stenoses, which in turn play a key role in the selection of patients for revascularization. 2 In clinical practice, stenosis severity is typically determined during or shortly after the procedure and most commonly relies on visual estimation by physicians. This approach, however, has well-known limitations. 3, 4 Older studies, conducted a decade or more ago, described interobserver and intraobserver variation in visual estimations of stenosis severity and inaccuracies compared with computer-assisted techniques, expert panel review, autopsy results, or simulations. [5] [6] [7] [8] [9] [10] [11] [12] [13] Despite the potential implications of these findings, particularly for the consistency and quality of treatment decisions for revascularization, 13 no widespread efforts have been undertaken to improve clinical interpretations of coronary angiograms, nor has there been further study of the issue.
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We lack contemporary information about the quality of clinical interpretations of coronary angiograms. Since studies were last performed in the early 1990s, significant advances in digital technology have transformed angiographic imaging. 14 Whether this has led to concomitant improvements in clinical interpretations is largely uncertain, however. Understanding this issue is relevant given that stenosis severity, as assessed by physicians, remains a pivotal variable for framing treatment options, even in the current era when preprocedural or intraprocedural functional testing of a stenosis is widely available. Moreover, the percent diameter stenosis continues to be used as an entry criterion for clinical trials of revascularization, and its reliable measurement is a key assumption of current appropriate use criteria for revascularization. 15 Errors in the clinical interpretation of coronary angiograms therefore have important consequences for treatment decisions, potentially leading to both overuse and underuse of revascularization.
To explore the quality of clinical interpretation in the modern era of interventional cardiology, we designed the Assessing Angiography (A2) project. We randomly selected coronary angiograms from patients undergoing percutaneous coronary intervention (PCI) at 7 large US hospitals. The clinical interpretation of stenosis severity among lesions with PCI by physicians was compared with measurements made by an independent, blinded review using state-of-the-art quantitative coronary angiography (QCA), a computer-assisted technique for measuring stenosis severity used for decades for quality assurance within clinical trials. 16 We purposely selected QCA as a benchmark tool because of its high reproducibility and potential freedom from observer influence and bias.
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Methods
Data Sources and Clinical Abstraction
We enrolled 7 PCI hospitals participating in the CathPCI Registry of the National Cardiovascular Data Registry (NCDR), sponsored by the American College of Cardiology and the Society for Cardiovascular Angiography and Intervention. We selected sites for this study to ensure diversity in regional location. We included only sites that had digital storage capability and could transfer coronary angiograms digitally for further assessment and interpretation. The investigators were responsible for all data collection and analyses, as well as the decision to publish the findings. The study was initially designed to produce information that could be used for a future quality improvement initiative by initiating feedback to participating hospitals on the correlation of their clinical interpretation of coronary angiograms with QCA from a core laboratory. When a decision to publish these findings was made, we obtained approval from the Institutional Review Board of Saint Luke's Hospital (Kansas City, MO), where analyses were conducted as an exempted study because all data were deidentified at this point.
From each of the hospitals, we obtained coronary angiograms on patients who underwent PCI during the 2011 calendar year. Data managers at the NCDR generated a random list of patients at each hospital after excluding patients undergoing PCI for urgent or emergency indications. For each patient, we obtained the clinical report of the coronary angiogram and catheterization laboratory log, after they were stripped of all unique patient identifiers, and a deidentified digital copy of the coronary angiogram. Data abstracted directly from the clinical records (not the CathPCI Registry) included information on catheter size, lesion location, maximal percent diameter stenosis before and after PCI, and use of fractional flow reserve (FFR). In cases when multiple lesions were described and treated, we abstracted data pertaining to each lesion. We obtained supplemental information on the clinical characteristics and presentation of each patient from each site as part of the data that were routinely collected and provided to the CathPCI Registry.
Quantitative Coronary Angiography
The deidentified clinical records and angiograms were managed by ImageCor, LLC (Bradenton, FL) and analyzed by the Yale Cardiovascular Research Group (New Haven, CT), an experienced core laboratory. The trained analysts at the core laboratory were blinded to the clinical records and worked independently of the sites and other investigators. The analysts first subjectively evaluated the overall technical quality of the images and stenosis visualization in multiple views using standardized criteria based on availability of imaging a calibration catheter, the presence of excessive foreshortening, vessel or side-branch overlap, contrast streaming or streaming artifact, limited ostial bifurcation imaging (excessive overlap or inadequate separation of vessels), and overexposure or underexposure.
The core laboratory then used the Cardiovascular Measurement System (QAngio XA 7.2, MEDIS, Leiden, the Netherlands), a personal computer-based system, for off-line quantitative angiographic analysis. Specific features of the CMS include 2-point user-defined path line (centerline) identification, arterial contour detection with a minimal-cost matrix algorithm, and an interpolated reference vessel diameter. The interpolated reference vessel diameter is a broadly accepted and well-validated method of measuring reference diameter by QCA; it is obtained at the site of minimal lumen diameter and derived by an iterative linear regression technique that is operator independent and accounts for vessel tapering. 18, 19 The minimal lesion diameter was used to calculate percent diameter stenosis relative to the interpolated reference vessel diameter of the lesion of interest. The core laboratory assessed the reference and minimal lesion diameters from the single-best-available projection with the least foreshortening that best demonstrated the stenosis as selected by the analyst. At the Yale Cardiovascular Research Group core laboratory, repeated QCA analyses of reference and minimal lumen diameters have demonstrated good reproducibility in a range of 3.7% to 5.8% for estimates of percent diameter stenosis (Alexandra J. Lansky, MD, personal communication, January 2013).
Data Analysis
We used univariate statistics to describe the study population. We then used a lesion-specific approach to compare the percent diameter stenosis by the 2 methods of assessment, and this was expressed as the difference between the clinical interpretation and QCA by the use of Student t tests. Concordance was further analyzed with 2 quantitative methods. First, we evaluated the correlation between clinical interpretation and QCA as continuous variables using the Pearson correlation coefficient and graphically presented these data, including a simple linear regression by guest on April 23, 2017 http://circ.ahajournals.org/ Downloaded from analysis. Second, we categorized percent diameter stenosis from 2 methods according to the following cutoffs: <50%, 50% to <70%, 70% to <90%, 90% to <100%, and 100% (but explored additional cutoffs in sensitivity analyses). We then assessed concordance between clinical interpretation and QCA using the Cohen weighted κ statistic, 20 a statistical measure of interrater agreement for categorical items. The κ statistic is generally considered a more robust measure than a simple percent agreement calculation because it considers agreement occurring by chance. Because the κ statistic takes the observed frequencies of categories as givens, it may underestimate agreement for a category that is also commonly used. Given this concern, the κ statistic is considered an overly conservative measure of agreement. 21 We also performed subgroup analyses. We first repeated our analyses after excluding patients with lesions thought to be associated with a recent non-ST-segment-elevation myocardial infarction or within coronary artery bypass grafts because the thresholds for revascularization based on percent diameter stenosis may be different in these circumstances. We also examined variation in angiographic interpretation across differences in stenosis severity, lesion location in the coronary vasculature, lesion reference vessel diameter, lesion length, quality of the coronary angiogram determined by the core laboratory, presence of a stress test or FFR, and individual hospital sites. The sample size for this study was difficult to estimate because of the intent of the study to generate basic descriptive information about agreement between clinical interpretations and QCA. We proposed to collect 25 studies from each of 8 hospitals; 7 hospitals ultimately participated in the quality improvement initiative. All analyses were conducted with SAS (version 9.3) and R (version 2.15.0) software.
Results
Study Population
The study sample included 175 patients who underwent PCI of 228 lesions at the 7 sites. A list of baseline characteristics is given in Table 1 . The mean age of patients was 66.7±10.7 years; 59 (33.7%) were women; and 20 (11.4%) were nonwhite. A history of prior PCI was present in 73 patients (41.7%), and prior coronary artery bypass grafting was present in 42 (24.0%). At the time of PCI, 26 patients (14.8%) were asymptomatic or had symptoms unlikely to be ischemic, 48 (27.4%) had stable angina, 87 (49.7%) had unstable angina, and 14 (8.0%) had a non-ST-segment-elevation myocardial infarction. A stress test was performed before PCI in 100 patients (57.1%). Table 2 lists characteristics associated with the 228 lesions that were treated by PCI in the study population. Most treated lesions were in the left anterior descending coronary artery, followed by the right coronary artery and left circumflex coronary artery. Of the 16 FFR assessments performed, 13 were abnormal, with values ≤0.80. In 216 lesions, a clinical interpretation with percent diameter stenosis was available, whereas the remaining 12 lesions were reported in qualitative terms (eg, severe or critical; Table 2 ). These 12 were excluded from analyses evaluating concordance.
Of the 216 lesions treated with PCI in which stenosis severity by clinical interpretation was reported, median percent diameter stenosis was 80.0% (first and third quartiles, 80% and 90%) and mean percent diameter stenosis was 84.2% (±10.1). The most commonly reported percent diameter stenoses were in the range of 70% to <90%, followed by 90% to <100%. In only 3 lesions (1.4%) was the percent diameter stenosis reported to be <70% by clinical interpretation; a stress test was documented (although information on specific results is unavailable) or an FFR was performed in these 3 patients. No lesion was reported to be <50%. The mean difference in percent diameter stenosis between the clinical interpretation and QCA was 8.2±8.4% (n=216), reflecting an average higher percent diameter stenosis by the clinical interpretation (P<0.001). The distribution of this difference across the lesions is shown in Figure 1 . Of the 213 lesions considered ≥70% by clinical assessment, 56 (26.3%) were measured at <70% by QCA and 10 (4.7%) were <60%.
A scatterplot of the clinical interpretation and quantitative assessment by QCA is displayed in Figure 2 , demonstrating a Pearson correlation coefficient of 0.68. Clinical interpretations had a discrete distribution, with most of the reported values being divisible by 10% (70%, 80%, etc), whereas QCA stenoses were continuously distributed. Table 3 shows a comparison between the 2 methods after categorizing each assessment according to clinically meaningful cutoffs and showing agreement. In this analysis, a weighted κ of 0.27 (95% confidence interval, 0.18-0.36) was found between the 2 measurements.
Our findings were essentially unchanged when we repeated our analyses after excluding patients with lesions associated with non-ST-segment-elevation myocardial infarction or within coronary artery bypass grafts (see Tables II and III and  Figures I and II in the online-only Data Supplement). Finally, we found that the mean difference in percent diameter stenosis between the clinical interpretation and QCA was greatest for lesions between 50% and <70% by QCA but diminished with higher stenosis severity (Table 4) . Less variation in the mean difference in percent diameter stenosis between the 2 methods was noted across several other subgroups (Table 4) , except for variation across individual hospital sites, which ranged from 5.6% to 11.2% (Figure 3 ). Using alternative cutoffs to categorize lesions by percent diameter stenosis from 2 methods did not lead to substantial differences in our results (Table IV in the online-only Data Supplement).
Discussion
We found significant differences between the percent diameter stenosis of a lesion as assessed by clinical interpretation and QCA in patients undergoing PCI at 7 US hospitals. In general, the clinical interpretation by physicians was ≥70% in most treated lesions, whereas approximately one quarter of the measurements by QCA were below that level. However, the extent of differences was 8% on average, and no lesion was <50% by QCA. Overall, findings from our study suggest potential opportunities for improving the clinical interpretation of coronary angiograms in routine practice, thus optimizing the selection and care of patients considered for revascularization.
The clinical value of any imaging test depends on several factors, including the acquisition and interpretation of the images and incorporation of this information into clinical decision making. Despite the many technical advances that have transformed the ways in which image acquisition now occurs with coronary angiography, little work has been done on developing strategies for improving its interpretation over the years. Indeed, interpretation may be even more challenging today because more decisions about revascularization are made during or just after the procedure is performed to maximize efficiency and to minimize costs (ie, ad hoc PCI). 22 This may limit what formerly occurred through collective discussions (eg, cath conference), despite earlier evidence that group reads significantly improve the accuracy of interpretations. 23, 24 Thus, our findings of the inconsistency between the clinical interpretation and an independent measurement by QCA, particularly for lower-severity stenoses, raise concerns. Despite their limitations, newer-generation QCA systems have high reproducibility and precision in quantifying stenosis severity even in complex lesions, 25 which have contributed to its widespread use in clinical trials of revascularization. Although differences between the clinical interpretation and QCA in an isolated patient should never be considered an automatic flag for inappropriate PCI, identifying where inconsistencies exist may provide opportunities for clinicians to understand ways to improve. For example, routine feedback on overreads of coronary angiograms through educational initiatives could enhance clinical decision making on the need for further testing (eg, FFR) before PCI. In our study, for example, use of FFR was relatively uncommon despite its growing role in the assessment of the physiological significance of angiographic lesions and determinations of revascularization. Expanded use of FFR, as well as techniques like digital calipers and online QCA, may be tools that could improve assessment of stenosis severity by clinical interpretation. 1 Providing feedback to hospitals also may be useful for improving clinical interpretation because we noticed facilitylevel variation in the mean difference in percent diameter stenosis between the 2 methods despite the small number included in this analysis. In this context, our findings may be particularly important for quality assurance programs. Although earlier efforts have focused on improving the selection and quality of care for PCI patients through clinical registries, 26 practical constraints have forced such programs to focus largely on evaluating data obtained via chart abstraction, rather than validating the accuracy of the primary data on which clinical decisions are made, in this case, stenosis severity. Recently, these concerns were exacerbated by highprofile cases in which cardiac surgeons and cardiologists were accused of performing revascularization on patients with coronary artery disease of questionable severity. 27, 28 Some of these providers have consistently reported better-thanexpected outcomes 29 because treating mild coronary artery disease is almost always safe for patients despite providing little benefit. This underscores the limitations of quality assurance tools that focus largely on chart abstraction and assessing complications.
Challenges exist when considering the potential next steps that may result from our findings. New approaches need to be developed for improving clinical interpretation through innovative educational initiatives or quality assurance programs. Given its potential scalability, QCA may be an efficient method for achieving these objectives, but this is unknown. In particular, it is necessary to examine how QCA or other methods to improve clinical interpretation may be integrated into the busy workflow of interventional cardiology. This must be done in a critical and rigorous manner because the addition of such tools does not necessarily result in improvement. For example, data on the clinical value of computerassisted screening mammography in routine practice have been mixed. 30, 31 Our study should be interpreted in the context of the following limitations. First, we examined only patients undergoing PCI. We did not perform QCA in lesions that were considered clinically insignificant or managed medically or surgically; our findings are not relevant to those settings, which will require additional investigations. Second, QCA itself has limitations. Thus, this study was focused specifically on assessing the quality of the clinical interpretation of the coronary angiogram, not the appropriateness of the clinical decision to intervene. For example, QCA does not include information on the hemodynamic significance of a stenosis. In isolation, it does not account for many factors that should influence clinical decisions on revascularization, nor does it alone predict long-term outcomes after treatment. 32 Nevertheless, accurate assessment of stenosis severity is essential for physicians and patients because this remains arguably the most critical factor in practical, day-to-day decisions about revascularization. Even current appropriate use criteria that emphasize the importance of symptoms and functional testing assume the presence of a significant stenosis of ≥70% luminal diameter narrowing by visual assessment before revascularization. Of course, future work needs to tie findings such as ours directly to clinical decisions and outcomes. Third, calculating stenosis severity by QCA still requires satisfactory image acquisition and minimal user input to identify imaging frames for analysis, which also may introduce variability. For this reason, our assessments were performed by analysts blinded to the clinical interpretation and at a core laboratory with broad experience in regulatory studies involving QCA. Fourth, our study was limited to 7 hospitals. These were primarily highvolume PCI centers, and importantly, each center volunteered to participate as part of a pilot quality improvement initiative. Whether our findings are applicable to a more broadly representative group of hospitals is uncertain, although the results may represent a best-case scenario. It may be that coronary angiograms at other hospitals may have technical deficiencies not found here, particularly with imaging for more complex lesions. Finally, because of our limited sample size, we were unable to examine variability in assessments of stenosis severity by physician. Future work needs to better quantify the effects of both hospital-and physician-level variation on clinical interpretation.
Conclusions
We found that physicians tended to assess lesions treated by PCI as more severe than measurements by QCA. Findings from our study are consistent with older work and suggest possible opportunities to further improve clinical interpretation of 
